Literature DB >> 30547186

MicroRNA-124 inhibits TNF-α- and IL-6-induced osteoclastogenesis.

Kenichiro Ohnuma1,2, Shimpei Kasagi1,2, Kenichi Uto2, Yoriko Noguchi2, Yuji Nakamachi2, Jun Saegusa1,2, Seiji Kawano3.   

Abstract

Receptor activator for nuclear factor κB ligand (RANKL)-independent osteoclastogenic pathway was reported recently. MicroRNA (miR)-124 has been known to suppress RANKL-dependent osteoclastogenesis by inhibiting NFATc1 expression. However, whether miR-124 regulates a RANKL-independent pathway has not been elucidated. In this study, we examined whether a RANKL-independent pathway is regulated by miR-124 in addition to the RANKL-dependent one. Using osteoclastogenic culture and pit-formation assay, we found that a miR-124 mimic inhibited osteoclastogenesis in mouse bone marrow-derived macrophages stimulated by TNF-α, IL-6, and M-CSF in the presence of osteoprotegerin. We also showed that the expression levels of osteoclast-specific genes and NFATc1 protein were suppressed in the miR-124 mimic-transfected cells by performing quantitative-polymerase chain reaction and western blotting. Our results indicate that miR-124 is important in inhibiting both RANKL-dependent and -independent osteoclast differentiation by suppressing NFATc1-mediated pathway.

Entities:  

Keywords:  Interleukin-6; MicroRNA-124; Osteoclast; RANKL-independent osteoclastogenesis; Rheumatoid arthritis; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2018        PMID: 30547186     DOI: 10.1007/s00296-018-4218-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.

Authors:  F Hemingway; R Taylor; H J Knowles; N A Athanasou
Journal:  Bone       Date:  2010-12-28       Impact factor: 4.398

Review 4.  Rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Iain B McInnes
Journal:  Lancet       Date:  2016-05-03       Impact factor: 79.321

5.  Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro.

Authors:  G Hattersley; J Owens; A M Flanagan; T J Chambers
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

6.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation.

Authors:  Hayatoshi Shibuya; Tomoyuki Nakasa; Nobuo Adachi; Yoshihiko Nagata; Masakazu Ishikawa; Masataka Deie; Osami Suzuki; Mitsuo Ochi
Journal:  Mod Rheumatol       Date:  2012-08-19       Impact factor: 3.023

8.  RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.

Authors:  William O'Brien; Brian M Fissel; Yukiko Maeda; Jing Yan; Xianpeng Ge; Ellen M Gravallese; Antonios O Aliprantis; Julia F Charles
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

9.  Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.

Authors:  Désirée van der Heijde; Yoshiya Tanaka; Roy Fleischmann; Edward Keystone; Joel Kremer; Cristiano Zerbini; Mario H Cardiel; Stanley Cohen; Peter Nash; Yeong-Wook Song; Dana Tegzová; Bradley T Wyman; David Gruben; Birgitta Benda; Gene Wallenstein; Sriram Krishnaswami; Samuel H Zwillich; John D Bradley; Carol A Connell
Journal:  Arthritis Rheum       Date:  2013-03

10.  MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  Yuji Nakamachi; Seiji Kawano; Mariko Takenokuchi; Kunihiro Nishimura; Yoshitada Sakai; Takaaki Chin; Ryuichi Saura; Masahiro Kurosaka; Shunichi Kumagai
Journal:  Arthritis Rheum       Date:  2009-05
View more
  5 in total

1.  High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.

Authors:  Paula López; Erika Girardi; Bryan C Mounce; Amélie Weiss; Béatrice Chane-Woon-Ming; Mélanie Messmer; Pasi Kaukinen; Arnaud Kopp; Diane Bortolamiol-Becet; Ali Fendri; Marco Vignuzzi; Laurent Brino; Sébastien Pfeffer
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 2.  Regulation of osteoclast-mediated bone resorption by microRNA.

Authors:  Ling Ji; Xinyi Li; Shushu He; Song Chen
Journal:  Cell Mol Life Sci       Date:  2022-05-10       Impact factor: 9.261

3.  Paeoniflorin reduces the inflammatory response of THP-1 cells by up-regulating microRNA-124 : Paeoniflorin reduces the inflammatory response of THP-1 cells through microRNA-124.

Authors:  Danyun Huang; Zhijun Li; Yue Chen; Yan Fan; Tao Yu
Journal:  Genes Genomics       Date:  2021-03-29       Impact factor: 1.839

Review 4.  Roles of MicroRNAs in Bone Destruction of Rheumatoid Arthritis.

Authors:  Hanxiao Zhao; Aiping Lu; Xiaojuan He
Journal:  Front Cell Dev Biol       Date:  2020-11-19

5.  The Profile of Markers of Bone Turnover, Inflammation and Extracellular Neutrophil Traps on Bone Mass in Haemophilia and the Development of Haemophilic Arthropathy.

Authors:  Sylwia Czajkowska; Joanna Rupa-Matysek; Ewelina Wojtasińska; Kacper Nijakowski; Anna Surdacka; Lidia Gil
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.